- Total Voting Rights Update
- Block Listing 6 Monthly Return
- Block Listing Application
- KYE Pharmaceuticals Files Accrufer® NDS in Canada
- Investor Presentation
- Second Price Monitoring Extn
- Price Monitoring Extension
- Full Year Trading Update
- KOL Investor Event on Iron Deficiency
- Licence Agreement in Canada for Accrufer®
More ▼
Key statistics
On Monday, Shield Therapeutics PLC (STX:LSE) closed at 14.62, 0.83% above its 52-week low of 14.50, set on May 16, 2022.
52-week range
Markit short selling activity
Open | 15.50 |
---|---|
High | 14.62 |
Low | 14.62 |
Bid | 14.50 |
Offer | 16.00 |
Previous close | 15.25 |
Average volume | 573.86k |
---|---|
Shares outstanding | 216.19m |
Free float | 115.80m |
P/E (TTM) | -- |
Market cap | 34.59m GBP |
EPS (TTM) | -0.0817 GBP |
Data delayed at least 20 minutes, as of May 16 2022 16:35 BST.
More ▼
Investors Chronicle View
The last IC recommendation on Shield Therapeutics PLC shares was Hold at 155.00 on 08 Aug 2019Read the full article